
USA - New York Stock Exchange - NYSE:HTA - US42225P5017 - REIT
ChartMill assigns a Buy % Consensus number of 71% to HTA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-10 | Berenberg | Upgrade | Hold -> Buy |
| 2022-02-01 | Credit Suisse | Initiate | Outperform |
| 2021-11-24 | Berenberg | Downgrade | Buy -> Hold |
| 2021-09-30 | Truist Securities | Downgrade | Buy -> Hold |
| 2021-08-20 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2021-08-04 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2021-04-08 | SMBC Nikko | Downgrade | Outperform -> Neutral |
| 2021-03-15 | Morgan Stanley | Maintains | Equal-Weight |
14 analysts have analysed HTA and the average price target is 33.72 USD. This implies a price increase of 15.53% is expected in the next year compared to the current price of 29.19.
The consensus rating for HEALTHCARE TRUST OF AME-CL A (HTA) is 71.4286 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering HEALTHCARE TRUST OF AME-CL A (HTA) is 14.